These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 7479568)

  • 1. Gastric pH influences the appearance of double peaks in the plasma concentration-time profiles of cimetidine after oral administration in dogs.
    Mummaneni V; Amidon GL; Dressman JB
    Pharm Res; 1995 May; 12(5):780-6. PubMed ID: 7479568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variable gastric emptying and discontinuities in drug absorption profiles: dependence of rates and extent of cimetidine absorption on motility phase and pH.
    Langguth P; Lee KM; Spahn-Langguth H; Amidon GL
    Biopharm Drug Dispos; 1994 Dec; 15(9):719-46. PubMed ID: 7888602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variability in cimetidine absorption and plasma double peaks following oral administration in the fasted state in humans: correlation with antral gastric motility.
    Takamatsu N; Welage LS; Hayashi Y; Yamamoto R; Barnett JL; Shah VP; Lesko LJ; Ramachandran C; Amidon GL
    Eur J Pharm Biopharm; 2002 Jan; 53(1):37-47. PubMed ID: 11777751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions of cimetidine and ranitidine with aluminum-containing antacids and a clay-containing gastric-protective drug in an "artificial stomach-duodenum" model.
    Vatier J; Harman A; Castela N; Droy-Lefaix MT; Farinotti R
    J Pharm Sci; 1994 Jul; 83(7):962-6. PubMed ID: 7965675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of variable gastric emptying and intestinal transit rates on the plasma level curve of cimetidine; an explanation for the double peak phenomenon.
    Oberle RL; Amidon GL
    J Pharmacokinet Biopharm; 1987 Oct; 15(5):529-44. PubMed ID: 3694496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of cimetidine in dogs after oral administration of cimetidine tablets.
    Le Traon G; Burgaud S; Horspool LJ
    J Vet Pharmacol Ther; 2009 Jun; 32(3):213-8. PubMed ID: 19646084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Applications and simulations of a discontinuous oral absorption pharmacokinetic model.
    Witcher JW; Boudinot FD
    Pharm Res; 1996 Nov; 13(11):1720-4. PubMed ID: 8956341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of cimetidine co-administration on the pharmacokinetics of acebutolol enantiomers and its metabolite diacetolol in a rat model: the effect of gastric pH on double-peak phenomena.
    Mostafavi SA; Foster RT
    Int J Pharm; 2003 Apr; 255(1-2):81-6. PubMed ID: 12672604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of the antacid Maalox and the H2-antagonist cimetidine on the pharmacokinetics of cerivastatin.
    Mück W; Ritter W; Dietrich H; Frey R; Kuhlmann J
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):261-4. PubMed ID: 9208343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and pharmacodynamics of oral and intravenous cimetidine in seriously ill patients.
    Sandborn WJ; Forland SC; Cutler RE; Strong RM
    J Clin Pharmacol; 1990 Jun; 30(6):568-71. PubMed ID: 2355107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cimetidine on absorption of oral tetracycline in mice.
    Garty M; Hurwitz A
    Pharmacology; 1980; 20(3):155-9. PubMed ID: 7384196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of 200 mg cimetidine with multiple doses of antacid on extent and duration of rise in gastric pH in volunteers.
    Thomson AB; Kirdeikis P; Zuk L
    Dig Dis Sci; 1999 Oct; 44(10):2051-5. PubMed ID: 10548357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of gastric acid secretion reduces zinc absorption in man.
    Sturniolo GC; Montino MC; Rossetto L; Martin A; D'Inca R; D'Odorico A; Naccarato R
    J Am Coll Nutr; 1991 Aug; 10(4):372-5. PubMed ID: 1894892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole-body physiologically based pharmacokinetic population modelling of oral drug administration: inter-individual variability of cimetidine absorption.
    Willmann S; Edginton AN; Kleine-Besten M; Jantratid E; Thelen K; Dressman JB
    J Pharm Pharmacol; 2009 Jul; 61(7):891-9. PubMed ID: 19589231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of cimetidine and antacids on gastrointestinal absorption of tetracycline.
    Garty M; Hurwitz A
    Clin Pharmacol Ther; 1980 Aug; 28(2):203-7. PubMed ID: 7398187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a Physiologically Relevant Population Pharmacokinetic in Vitro-in Vivo Correlation Approach for Designing Extended-Release Oral Dosage Formulation.
    Kim TH; Shin S; Bulitta JB; Youn YS; Yoo SD; Shin BS
    Mol Pharm; 2017 Jan; 14(1):53-65. PubMed ID: 27809538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study comparing the antisecretory effect of TAK-438, a novel potassium-competitive acid blocker, with lansoprazole in animals.
    Hori Y; Matsukawa J; Takeuchi T; Nishida H; Kajino M; Inatomi N
    J Pharmacol Exp Ther; 2011 Jun; 337(3):797-804. PubMed ID: 21411494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative pharmacodynamics and pharmacokinetics of cimetidine and ranitidine.
    Richards DA
    J Clin Gastroenterol; 1983; 5 Suppl 1():81-90. PubMed ID: 6317740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A dosage alternative for H2-receptor antagonists--constant infusion.
    Siepler JK
    Clin Ther; 1986; 8 Suppl A():24-33. PubMed ID: 2878728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro dissolution methodology, mini-Gastrointestinal Simulator (mGIS), predicts better in vivo dissolution of a weak base drug, dasatinib.
    Tsume Y; Takeuchi S; Matsui K; Amidon GE; Amidon GL
    Eur J Pharm Sci; 2015 Aug; 76():203-12. PubMed ID: 25978875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.